TY - JOUR
T1 - A novel pathway for glycan assembly
T2 - Biosynthesis of the glycosyl-phosphatidylinositol anchor of the trypanosome variant surface glycoprotein
AU - Masterson, Wayne J.
AU - Doering, Tamara L.
AU - Hart, Gerald W.
AU - Englund, Paul T.
N1 - Funding Information:
We thank Drs. Dan Raben, Sharon Krag, and Kojo Mensa-Wilmot for comments on the manuscript. Support was provided by the National Institutes of Health (grant Al-21334) and the MacArthur Foundation. T. L. D. was supported by Medical Scientist Training Grant 5T32GMO-7309.
PY - 1989/3/10
Y1 - 1989/3/10
N2 - The trypanosome variant surface glycoprotein (VSG), like many other eukaryotic cell surface proteins, is anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety. This glycolipid is assembled first as a precursor (glycolipid A) that is then covalently attached to the newly synthesized polypeptide. We have developed a trypanosome cell-free system capable of performing all of the steps in the biosynthesis of the glycan portion of glycolipid A. Using [3H]sugar nucleotides as substrates, several biosynthetic intermediates have been identified. From structural analyses of these intermediates, we propose a pathway for GPI biosynthesis. Based on comparisons between the VSG GPI anchor and similar structures in other cells, we believe that this same pathway will apply to the GPI anchors, and the related insulin-mediator compound, of higher eukaryotes.
AB - The trypanosome variant surface glycoprotein (VSG), like many other eukaryotic cell surface proteins, is anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety. This glycolipid is assembled first as a precursor (glycolipid A) that is then covalently attached to the newly synthesized polypeptide. We have developed a trypanosome cell-free system capable of performing all of the steps in the biosynthesis of the glycan portion of glycolipid A. Using [3H]sugar nucleotides as substrates, several biosynthetic intermediates have been identified. From structural analyses of these intermediates, we propose a pathway for GPI biosynthesis. Based on comparisons between the VSG GPI anchor and similar structures in other cells, we believe that this same pathway will apply to the GPI anchors, and the related insulin-mediator compound, of higher eukaryotes.
UR - https://www.scopus.com/pages/publications/0024515848
U2 - 10.1016/0092-8674(89)90684-3
DO - 10.1016/0092-8674(89)90684-3
M3 - Article
C2 - 2924349
AN - SCOPUS:0024515848
SN - 0092-8674
VL - 56
SP - 793
EP - 800
JO - Cell
JF - Cell
IS - 5
ER -